PLATEAU study

Not Applicable

• Conditions: D000086382; coronavirus disease 2019 (COVID-19); SARS-CoV-2

• Registration Number: JPRN-jRCTs071210097
• Lead Sponsor: Mukae Hiroshi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-06
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Subjects who meet all of the following criteria are included in this study:
1. Subjects who are SARS-CoV-2 positive
2. Subjects whose SpO2 is 96% or higher
3. Male or female who are aged of 20 years or older and younger than 65 years
4. Subjects who do not refuse to disclose their vaccination status
5. Subjects who can be recuperated at recuperation accommodations designated by Nagasaki prefecture*
6. Subjects who give their written consent form to participate in the study
* Subjects who are decided to be hospitalized at giving their consent can be enrolled.

Exclusion Criteria

Subjects who fall into any of the following criteria are excluded from participating in the study:
1. Obese subjects (BMI >= 30 kg/m2)
2. Subjects who have strong dyspnea, chest pain, or bloody sputum
3. Subjects with history of COVID-19
4. Subjects who are being treated or will be treated by neutralizing antibody preparations
5. Subjects who are being treated by immunosuppressive agents, antirheumatic agents, corticosteroids, or immunoglobulin preparations at giving their consent
6. Subjects who are administered intestinal regulators orally
7. Subjects who are taking one or more beverage or foods that contain Lactococcus lactis strain Plasma or yogurt (that contain lactic acid bacteria or Lactobacillus bulgaricus) everyday
8. Subjects who are pregnant, possibly pregnant, or breastfeeding
9. Subjects who are participating in other clinical trials at giving their consent
10. Subjects who need legal representative for giving consent
11. Subjects with other conditions that the responsible investigator or subinvestigators think inappropriate to participate in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified